Stabilizing Camptothecin Pharmaceutical Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2016/057247, filed Oct 15, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,456,360 | Stabilizing Camptothecin Pharmaceutical Compositions In force · Medium confidence UsedRemaining | Ipsen Biopharm Ltd. | In force | Medium confidence | ||
| US 10,993,914 | Stabilizing Camptothecin Pharmaceutical Compositions In force · Medium confidence | Ipsen Biopharm Ltd. | In force | Medium confidence | ||
| US 12,059,497 | Stabilizing Camptothecin Pharmaceutical Compositions In force · Medium confidence | Ipsen Biopharm Ltd. | In force | Medium confidence | ||
| Application 15/331,318 | Liposomal Irinotecan Preparations Abandoned Abandoned Jul 28, 2017 | Ipsen Biopharm Ltd. | Abandoned | Abandoned Jul 28, 2017 | ||
| Application 15/331,393 | Liposomal Irinotecan Compositions Abandoned Abandoned Oct 18, 2017 | Ipsen Biopharm Ltd. | Abandoned | Abandoned Oct 18, 2017 | ||
| Application 15/331,648 | Liposomal Irinotecan Preparations Abandoned Abandoned Jul 11, 2017 | Ipsen Biopharm Ltd. | Abandoned | Abandoned Jul 11, 2017 | ||
| Application 15/661,868 | Stabilizing Camptothecin Pharmaceutical Compositions Abandoned Abandoned Jun 29, 2018 | Ipsen Biopharm Ltd. | Abandoned | Abandoned Jun 29, 2018 | ||
| Application 17/011,617 | Stabilizing Camptothecin Pharmaceutical Compositions Abandoned Abandoned Oct 11, 2022 | Ipsen Biopharm Ltd. | Abandoned | Abandoned Oct 11, 2022 | ||
| Application 17/899,933 | Stabilizing Camptothecin Pharmaceutical Compositions Abandoned Abandoned Oct 29, 2024 | Ipsen Biopharm Ltd. | Abandoned | Abandoned Oct 29, 2024 | ||
| Application 18/737,163 | Stabilizing Camptothecin Pharmaceutical Compositions Pending Not granted | Ipsen Biopharm Ltd. | Pending | Not granted | ||
| 5 more records in this group · Pro | ||||||
10 of 15 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 15.
3 of these are in force and held by Ipsen Biopharm Ltd..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.